Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population‐based assessment in seven million children
Cancer · 2024
DOI: 10.1002/cncr.35041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Gillean K Connolly und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Beckwith-Wiedemann Syndrome, Wilms Tumor, Kidney Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: US Department of Defense.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Overgrowth syndromes (e.g., Beckwith–Wiedemann) are associated with an increased risk of pediatric cancer, although there are few population‐based estimates of risk. There are also limited studies describing associations between other overgrowth features (e.g., hepatosplenomegaly) and pediatric cancer. Therefore, cancer risk among children with these conditions was evaluated with data from a large, diverse population‐based registry linkage study.
Methods
This study includes all live births in Texas during the years 1999–2017. Children with overgrowth features and syndromes were identified from the Texas Birth Defects Registry; children with cancer were identified by linkage to the Texas Cancer Registry. Cox regression models were used to estimate the hazard ratio (HR) and 95% confidence interval (CI) for the association between each overgrowth syndrome/feature and cancer, which were adjusted for infant sex and maternal age.
Results
In the total birth cohort ( n = 6,997,422), 21,207 children were identified as having an overgrowth syndrome or feature. Children with Beckwith–Wiedemann syndrome were 42 times more likely to develop pediatric cancer (95% CI, 24.20–71.83), with hepatoblastoma being the most common, followed by Wilms tumor. The presence of any isolated overgrowth feature was associated with increased cancer risk (HR, 4.70; 95% CI, 3.83–5.77); associations were strongest for hepatosplenomegaly (HR, 23.04; 95% CI, 13.37–39.69) and macroglossia (HR, 11.18; 95% CI, 6.35–19.70).
Conclusions
This population‐based assessment confirmed prior findings that children with either overgrowth syndromes or features were significantly more likely to develop cancer. Overall, this study supports recommendations for cancer surveillance in children with these conditions and may also inform future research into cancer etiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
- School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Environmental Epidemiology and Disease Registries Section, Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, Texas, USA.
ORCID-Profile: Rachel D Harris, Jeremy M Schraw, Philip J Lupo
Förderung
- US Department of Defense
Zitieren
APA
Connolly, G. K., Harris, R. D., Shumate, C., Rednam, S. P., Canfield, M. A., Plon, S. E., Nguyen, J., Schraw, J. M., & Lupo, P. J. (2024). Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population‐based assessment in seven million children. Cancer. https://doi.org/10.1002/cncr.35041
Vancouver
Connolly GK, Harris RD, Shumate C, Rednam SP, Canfield MA, Plon SE, et al. Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population‐based assessment in seven million children. Cancer. 2024. doi:10.1002/cncr.35041
BibTeX
@article{Connolly2024,
author = {Connolly, Gillean K and Harris, Rachel D and Shumate, Charles and Rednam, Surya P and Canfield, Mark A and Plon, Sharon E and Nguyen, Joanne and Schraw, Jeremy M and Lupo, Philip J},
title = {Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population‐based assessment in seven million children},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35041}
}
EUVIMED